启明医疗-B(02500)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02500 启明医疗-B

未开盘 09-28 16:08:26

1.210

+0.020

+1.68%

最高1.215	最低1.165	成交量22.50万
今开1.190	昨收1.190	日振幅4.20%
总市值5.34亿	流通市值5.34亿	总股本4.41亿
成交额26.89万	换手率0.05%	流通股本4.41亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02500","market":"HK","secType":"STK","nameCN":"启明医疗-B","latestPrice":1.21,"timestamp":1790582906485,"preClose":1.19,"halted":0,"volume":225000,"delay":0,"changeRate":0.016806722689075647,"floatShares":441010235,"shares":441011443,"eps":-1.0871267857563136,"marketStatus":"未开盘","change":0.02,"latestTime":"09-28 16:08:26","open":1.19,"high":1.215,"low":1.165,"amount":268915,"amplitude":0.042017,"askPrice":1.21,"askSize":12500,"bidPrice":1.18,"bidSize":67500,"shortable":0,"etf":0,"ttmEps":-1.2391842613382287,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790645400000},"marketStatusCode":0,"adr":0,"listingDate":1575907200000,"exchange":"SEHK","adjPreClose":1.19,"openAndCloseTimeList":[[1790559000000,1790568000000],[1790571600000,1790582400000]],"volumeRatio":0.3179313267660171,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02500","defaultTab":"news","newsList":[{"id":"1120700300","title":"启明医疗-B2026年中期营收1.35亿元，经调整净利润0.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1120700300","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1120700300?lang=zh_cn&edition=full","pubTime":"2026-09-23 16:43","pubTimestamp":1790153036,"startTime":"0","endTime":"0","summary":"2026年上半年，启明医疗-B实现营收1.35亿元，同比下降27.6%。毛利约为0.94亿元，同比下降32.2%。经调整净利润0.08亿元，同比下滑72.7%。商业化利润率为6.1%，较上年同期下降10.1个百分点。经营活动现金流净额约为-1.61亿元，而上年同期为-1.12亿元。报告期内，TAVR业务收入从上年同期的约1.38亿元降至约0.80亿元，同比下降42.5%。成本与费用方面，销售及分销开支为79.7百万元，同比下降20.7%；行政开支为51.7百万元，同比下降5.7%；研发投入约1.21亿元，较上年同期减少约6%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"启明医疗-B2026年中期营收1.35亿元，经调整净利润0.08亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179082700","title":"启明医疗-B（02500）拟于2026年9月30日召开临时股东会，同步暂停H股过户","url":"https://stock-news.laohu8.com/highlight/detail?id=1179082700","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179082700?lang=zh_cn&edition=full","pubTime":"2026-09-11 17:56","pubTimestamp":1789120570,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年9月11日公告，董事会已决议于2026年9月30日召开临时股东大会，审议《关于根据特别授权认购新股份及新可转换债券》的相关议案。为厘定有权出席临时股东大会的H股股东名单，公司将自2026年9月25日至2026年9月30日暂停办理H股股份过户登记手续。于2026年9月30日名列公司股东名册的H股及非上市外资股股东均有权出席会议并于会上投票。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666967845","title":"启明医疗-B(02500.HK)拟向杭州盈智勤三号股权投资合伙企业发行新股及可转换债券 募资不超过5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2666967845","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666967845?lang=zh_cn&edition=full","pubTime":"2026-09-10 21:20","pubTimestamp":1789046454,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","BK1574","BK1583","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187724011","title":"启明医疗-B拟引入5亿元战投资金 发行约1.85亿股及3.80亿港元可转债","url":"https://stock-news.laohu8.com/highlight/detail?id=1187724011","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1187724011?lang=zh_cn&edition=full","pubTime":"2026-09-10 21:15","pubTimestamp":1789046139,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司9月10日晚间公告，与杭州盈智勤叁号股权投资合伙企业签订认购协议，拟通过发行新股及可转债方式合计募资不超过人民币5亿元。交易需获得临时股东大会特别授权后方可实施。以下为交易主要条款：。发行股份数量：184,536,703股。发行价格：每股1.078港元。认购价格较9月10日收市价1.170港元折让7.9%。交易总投资额不超过人民币5亿元，其中3.50亿元为首次认购，另有最高1.50亿元追加额度。完成新股发行后总股本将增至625,548,146股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199029505","title":"启明医疗-B 8月未有新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1199029505","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1199029505?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:50","pubTimestamp":1788425402,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年9月3日披露了截至2026年8月31日止的证券变动月报表，披露了公司普通股H股以及非上市外资股在该月份的变动情况。报告期内，上述各类股份均未发生增减变动，发行股本维持不变。截至2026年8月末，该等回购股份尚未注销。公司表示，截至2026年8月31日，其股本总数稳定为441,011,443股，仍符合适用的公众持股量要求。本次公告由执行董事柳美荣签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664839899","title":"港股异动 | 启明医疗-B(02500)午后涨超13% 参投企业Pi-Cardia获美敦力8000万美金战略投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2664839899","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664839899?lang=zh_cn&edition=full","pubTime":"2026-09-02 13:59","pubTimestamp":1788328771,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，启明医疗-B午后涨超13%。截至发稿，涨13.24%，报1.155港元，成交额243.90万港元。消息面上，启明医疗参与投资千万美金的以色列创新医疗器械公司Pi-Cardia宣布获得美敦力8,000万美金的战略投资，在达成里程碑后，美敦力有权以不超过2.1亿美元的对价收购Pi-Cardia。此次合作标志着Shortcut产品进入全球商业化加速阶段，也将进一步巩固Pi-Cardia在结构性心脏病领域的创新领导者地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490833.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","KCAI","BK1100","VXUS","BK4585","BK4588","BK1574","02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663006123","title":"启明医疗-B(02500.HK)发布中期业绩，归母亏损1.91亿元 同比增加41.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663006123","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663006123?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:37","pubTimestamp":1788183457,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["02500","BK1100","BK1574","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1177534110","title":"启明医疗-B2026年上半年营收1.35亿元，经调整净利润0.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1177534110","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1177534110?lang=zh_cn&edition=full","pubTime":"2026-08-31 21:33","pubTimestamp":1788183213,"startTime":"0","endTime":"0","summary":"启明医疗-B披露了2026年上半年业绩。财报显示，期内营收约1.35亿元，同比下降27.6%。公司同期经调整净利润约为0.08亿元，同比下降72.7%，经调整商业化利润率为6.1%，较上年同期减少10.1个百分点。同一口径下，Non-GAAP EBITDA为-1.41亿元，亏损幅度同比扩大71.9%。公司方面表示，营业收入走低主要受到国内经导管主动脉瓣置换领域终端价格体系重塑及市场竞争加剧、手术量增速放缓等因素影响，而海外瓣膜业务则保持稳健增长，为整体业绩带来一定支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"启明医疗-B2026年上半年营收1.35亿元，经调整净利润0.08亿元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109142508","title":"启明医疗-B（02500）拟于8月31日召开董事会审议2026年中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1109142508","media":"公告速递","labels":["conferences","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1109142508?lang=zh_cn&edition=full","pubTime":"2026-08-19 16:35","pubTimestamp":1787128548,"startTime":"0","endTime":"0","summary":"启明医疗-B（02500）8月19日公告，公司董事会将于2026年8月31日（星期一）召开会议，审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布事宜，并处理其他事项。\n\n公告显示，董事会当前成员包括：执行董事林浩昇先生、柳美荣女士；非执行董事张奥先生、王瑋先生；独立非执行董事胡定旭先生、孫志偉先生及古軍華先生。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189827572","title":"启明医疗-B7月股份变动月报表 股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1189827572","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1189827572?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:45","pubTimestamp":1785919554,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年8月5日披露了2026年7月的股份变动月报表。截至2026年7月31日，公司已发行的股份包括441,010,235股H股和1,208股非上市外资股，合计441,011,443股。公司曾于2021年12月8日、17日及20日合计回购3,114,000股H股，但截至2026年7月31日尚未完成注销，未对当期已发行股份总数产生影响。此前，经2023年7月12日股东大会批准的一项购股权计划，目前可行使或转让的H股最高数量为44,101,023股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656120383","title":"服务从被动响应到主动感知转型 万科物业首创AI全域社区感知体系","url":"https://stock-news.laohu8.com/highlight/detail?id=2656120383","media":"经济参考网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656120383?lang=zh_cn&edition=full","pubTime":"2026-08-02 16:19","pubTimestamp":1785658742,"startTime":"0","endTime":"0","summary":"近日，万科物业宣布，在业内率先部署社区AI全域社区感知体系，推动物业服务从“被动响应”迈入“主动感知”的新阶段。沿袭多年的“五好”服务标准同步升级为“五好+”，让每一项服务都融入了AI能力，做得更精、更快、更省心。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608023829128868.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608023829128868.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","02202","000002","BK1507","BK1574","02500","BK1100","IE0034224299.USD","BK1555","BK1521","BK1240"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107987517","title":"启明医疗宣布完成全球首款全回收自膨式干瓣TAVR系统Venus-PowerX中国关键性临床试验患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1107987517","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1107987517?lang=zh_cn&edition=full","pubTime":"2026-07-23 14:01","pubTimestamp":1784786510,"startTime":"0","endTime":"0","summary":"启明医疗-B宣布，其全球首创的全回收、自膨式干瓣经导管主动脉瓣置换（TAVR）系统Venus-PowerX，在中国的关键性临床试验患者入组工作已顺利完成。这一里程碑标志着该创新器械的临床验证进程取得了重大进展，为其未来在中国市场的商业化应用奠定了关键基础。作为世界首款具备完全回收与再定位功能的自膨式干瓣TAVR产品，Venus-PowerX旨在为主动脉瓣狭窄患者提供更安全、更精准的微创治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1100","BK1583","02500","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163817568","title":"启明医疗-B6月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1163817568","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1163817568?lang=zh_cn&edition=full","pubTime":"2026-07-06 17:36","pubTimestamp":1783330581,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年7月6日公布2026年6月股份变动月报表。报告期为2026年6月，本月内公司股本结构整体保持稳定。报告显示，启明医疗-B于香港联交所上市的H股普通股数量在6月底为441,010,235股，与上月底一致；非上市外资股则维持1,208股不变。公司确认，其H股已符合香港联交所规定的最低公众持股量要求。公司在公告中表示，将继续严格遵守香港联交所《上市规则》及相关法律法规的要求。本份月报由执行董事柳美荣签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649119596","title":"启明医疗-B(02500)：发行可转换债券的认购协议失效","url":"https://stock-news.laohu8.com/highlight/detail?id=2649119596","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649119596?lang=zh_cn&edition=full","pubTime":"2026-07-06 06:46","pubTimestamp":1783291603,"startTime":"0","endTime":"0","summary":"智通财经APP讯，启明医疗-B 发布公告，根据认购协议(经修订)，倘先决条件未于截止日期或之前或认购人与公司可能商定的较后日期达成，则认购协议将失效及无效。根据框架协议，认购人已向公司支付过渡性贷款人民币1.5亿元。根据投资条款清单，于股东批准正式交易文件及其项下交易后30个工作日内，须完成认购总投资额为人民币3.5亿元并由公司发行的新股份及╱或新可转换债券。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1463275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CVRT","BK1574","02500","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648586646","title":"启明医疗-B午前大涨逾32% 公司与三方订立投资条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2648586646","media":"新浪港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648586646?lang=zh_cn&edition=full","pubTime":"2026-07-03 11:52","pubTimestamp":1783050720,"startTime":"0","endTime":"0","summary":"　　启明医疗-B午前涨超31%，截至发稿，股价上涨31.85%，现报1.78港元，成交额909.53万港元。　　启明医疗-B发布公告，于2026年7月1日，本公司、杭州高新及杭州盈智勤订立投资条款清单，据此，杭州高新及杭州盈智勤表示有意与其他潜在投资者透过潜在交易共同对本公司进行投资，总投资额最高达人民币5亿元。新可转换债券转换价为紧接正式交易文件签署前最后20个连续交易日在联交所所报股份的收市价的平均价格的110%，但转换价不超过每股2.5港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-07-03/doc-inifnxny5632898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1100","02500","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578112","title":"启明医疗：将获杭州高新及杭州盈智勤5亿元投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578112","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648578112?lang=zh_cn&edition=full","pubTime":"2026-07-02 09:27","pubTimestamp":1782955620,"startTime":"0","endTime":"0","summary":"7月2日，启明医疗（02500）发布公告，公司、杭州高新及杭州盈智勤订立投资条款清单，据此，杭州高新及杭州盈智勤表示有意与其他潜在投资者通过潜在交易（包括股份认购及可转换债券认购）共同对公司进行投资，总投资额最高达5亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607023791172754.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607023791172754.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","02500","BK0220","BK1583","BK0028","300478","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648522329","title":"启明医疗-B(02500.HK)、杭州高新及杭州盈智勤订立投资条款清单","url":"https://stock-news.laohu8.com/highlight/detail?id=2648522329","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648522329?lang=zh_cn&edition=full","pubTime":"2026-07-02 07:09","pubTimestamp":1782947384,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1100","02500","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128132346","title":"杭州启明医疗获杭州高新、杭州盈智勤最高5亿元投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1128132346","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128132346?lang=zh_cn&edition=full","pubTime":"2026-07-02 06:06","pubTimestamp":1782943608,"startTime":"0","endTime":"0","summary":"杭州启明医疗有望获得来自杭州高新及杭州盈智勤的股权投资，总额最高可达人民币5亿元。此次投资计划彰显了投资方对该公司未来发展前景的信心与支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184585182","title":"启明医疗-B5月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1184585182","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1184585182?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:51","pubTimestamp":1780480269,"startTime":"0","endTime":"0","summary":"杭州启明医疗器械股份有限公司于2026年6月3日发布截至2026年5月31日的股份变动月报表。公告显示，公司法定注册股本为人民币441,011,443元，其中包括441,010,235股H股及1,208股非上市外资股，面值均为人民币1元。相比上月底，5月内上述股本数量无增减。公告披露，截至5月末，公司已发行的H股为441,010,235股，未有任何新增发行或库存股份变化；非上市外资股为1,208股，也未有变动。公司确认符合香港联交所对于H股的公众持股要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150022016","title":"启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成","url":"https://stock-news.laohu8.com/highlight/detail?id=1150022016","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1150022016?lang=zh_cn&edition=full","pubTime":"2026-06-03 16:37","pubTimestamp":1780475861,"startTime":"0","endTime":"0","summary":"启明医疗-B宣布，已于最新公告中提呈授予董事会一般性授权，可在2026年6月25日股东大会批准后，于授权有效期内酌情购回不超过已发行及尚未购回H股总数10%的股份。于公告披露前的最后实际可行日期，该公司已发行及尚未购回的股份总数为441,011,443股，其中H股为441,010,235股，这意味着若获授权通过，购回规模最高可达44,101,023股。公司目前尚未持有任何库存股份，亦无接获核心关连人士向公司出售股份的通知。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"启明医疗-B授予董事会股份购回授权 规模最高达已发行H股一成","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.venusmedtech.com","stockEarnings":[{"period":"1week","weight":-0.0122},{"period":"1month","weight":0.21},{"period":"3month","weight":-0.0163},{"period":"6month","weight":-0.445},{"period":"1year","weight":-0.6231},{"period":"ytd","weight":-0.4916}],"compareEarnings":[{"period":"1week","weight":-0.016},{"period":"1month","weight":-0.0368},{"period":"3month","weight":0.077},{"period":"6month","weight":-0.0258},{"period":"1year","weight":-0.0569},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州启明医疗器械股份有限公司是一家主要从事生物心脏瓣膜的研发以及生产及销售从事生物心脏瓣膜的研发以及生产及销售的中国公司。该公司主要从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售。该公司的产品线已覆盖针对主动脉瓣、肺动脉瓣、二尖瓣、三尖瓣等心脏瓣膜类疾病介入治疗系列器械、肥厚型心肌病介入治疗的射频消融系统、高血介入治疗的肾动脉去交感神经超声消融系统以及其它手术配套耗材等。该公司的主要产品包括VenusA-Valve系統，VenusA-Plus系統，VenusA-Pilot系統，VenusP-Valve系統，TMVR 瓣膜, TTVR 瓣膜，瓣膜成形术球囊V8/TAV8及TriGUARD3脑栓塞保护仪器。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.8,"avgChangeRate":0.070986},{"month":2,"riseRate":0.2,"avgChangeRate":-0.071618},{"month":3,"riseRate":0,"avgChangeRate":-0.254926},{"month":4,"riseRate":0.666667,"avgChangeRate":0.054263},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.128903},{"month":6,"riseRate":0.666667,"avgChangeRate":0.098187},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.007273},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.114768},{"month":9,"riseRate":0.5,"avgChangeRate":0.001405},{"month":10,"riseRate":0.2,"avgChangeRate":-0.074139},{"month":11,"riseRate":0.6,"avgChangeRate":0.100743},{"month":12,"riseRate":0.5,"avgChangeRate":-0.006043}],"exchange":"SEHK","name":"启明医疗-B","nameEN":"VENUS MEDTECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"启明医疗-B(02500)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供启明医疗-B(02500)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"启明医疗-B,02500,启明医疗-B股票,启明医疗-B股票老虎,启明医疗-B股票老虎国际,启明医疗-B行情,启明医疗-B股票行情,启明医疗-B股价,启明医疗-B股市,启明医疗-B股票价格,启明医疗-B股票交易,启明医疗-B股票购买,启明医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"启明医疗-B(02500)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供启明医疗-B(02500)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}